Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Merad

Showing results (311-320 of 349) with videos related to

Pageof 35
Sort By:
Nature|December 6, 2023
An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesisNelson M LaMarche, Samarth Hegde, Matthew D Park, et al.
The Journal of Clinical Investigation|April 3, 2019
IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel diseaseLyssia Belarif, Richard Danger, Laetitia Kermarrec, et al.
Cancer Discovery|August 26, 2022
Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung TumorsJohn A Grout, Philemon Sirven, Andrew M Leader, et al.
Nature|November 14, 2017
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancerVinod P Balachandran, Marta Łuksza, Julia N Zhao, et al.
Nature Medicine|December 9, 2022
Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelaeRyan C Thompson, Nicole W Simons, Lillian Wilkins, et al.
Research Square|March 30, 2023
Proteomic Characterization of Acute Kidney Injury in Patients Hospitalized with SARS-CoV2 InfectionGirish Nadkami, Ishan Paranjpe, Pushkala Jayaraman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2024
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell CarcinomaChang Gon Kim, Min Hee Hong, Dahee Kim, et al.
Biorxiv : the Preprint Server for Biology|June 2, 2021
Structurally and functionally distinct early antibody responses predict COVID-19 disease trajectory and mRNA vaccine responseSaborni Chakraborty, Joseph C Gonzalez, Benjamin L Sievers, et al.
Science Translational Medicine|January 18, 2022
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severitySaborni Chakraborty, Joseph C Gonzalez, Benjamin L Sievers, et al.
Nature Communications|November 20, 2024
The commitment of the human cell atlas to humanityIdo Amit, Kristin Ardlie, Fabiana Arzuaga, et al.
Pageof 35

Showing results (311-320 of 349) with videos related to

Sort By:
Pageof 35
Nature|December 6, 2023
An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesisNelson M LaMarche, Samarth Hegde, Matthew D Park, et al.
The Journal of Clinical Investigation|April 3, 2019
IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel diseaseLyssia Belarif, Richard Danger, Laetitia Kermarrec, et al.
Cancer Discovery|August 26, 2022
Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung TumorsJohn A Grout, Philemon Sirven, Andrew M Leader, et al.
Nature|November 14, 2017
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancerVinod P Balachandran, Marta Łuksza, Julia N Zhao, et al.
Nature Medicine|December 9, 2022
Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelaeRyan C Thompson, Nicole W Simons, Lillian Wilkins, et al.
Research Square|March 30, 2023
Proteomic Characterization of Acute Kidney Injury in Patients Hospitalized with SARS-CoV2 InfectionGirish Nadkami, Ishan Paranjpe, Pushkala Jayaraman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2024
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell CarcinomaChang Gon Kim, Min Hee Hong, Dahee Kim, et al.
Biorxiv : the Preprint Server for Biology|June 2, 2021
Structurally and functionally distinct early antibody responses predict COVID-19 disease trajectory and mRNA vaccine responseSaborni Chakraborty, Joseph C Gonzalez, Benjamin L Sievers, et al.
Science Translational Medicine|January 18, 2022
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severitySaborni Chakraborty, Joseph C Gonzalez, Benjamin L Sievers, et al.
Nature Communications|November 20, 2024
The commitment of the human cell atlas to humanityIdo Amit, Kristin Ardlie, Fabiana Arzuaga, et al.
Pageof 35